chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Positive Covid test on 07Jan2022; Positive Covid test on 07Jan2022; Light Runny nose; Little cold one night; Tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 42 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 23Feb2021 (Lot number: EL3247) at the age of 42 years as dose 2, single and administered in arm left, administration date 03Feb2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 07Jan2022, outcome "recovered" (2022) and all described as "Positive Covid test on 07Jan2022"; RHINORRHOEA (non-serious) with onset 07Jan2022, outcome "recovered" (09Jan2022), described as "Light Runny nose"; NASOPHARYNGITIS (non-serious) with onset 07Jan2022, outcome "recovered" (09Jan2022), described as "Little cold one night"; FATIGUE (non-serious) with onset 07Jan2022, outcome "recovered" (09Jan2022), described as "Tired". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (07Jan2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19, rhinorrhoea, nasopharyngitis, fatigue. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, no medications within 2 weeks of vaccination and was not diagnosed with Covid-19, prior to vaccination. Positive Covid test on 07Jan2022 and he was told to report. Symptoms were very little, light runny nose, little cold one night, tired. Lasted for 2 days, and then felt good. Device date was reported as 11Jan2022.
pt had fever 103, lethargic (limp) following immun the evening p/immun administered;
This reaction happened at an offsite COVID clinic. Patient was complaining of having adverse reaction after receiving the vaccine, and was given Benadryl 25 mg (patient refused 50 mg). Patient was monitored for 30 minutes after vaccination, and was then released to Firstaid team. Patient was doing fine.
Pt appeared to have a seizure. Fell to the floor, unresponsive for 15 seconds. Hx  Hypertension and seizures.
Severe Joint Problems Respiratory Problems Sick like symptoms Blood Circulation problems migraines Soreness of muscles Fatigue
3x4 inch raised, warm, red swelling about 3 inches distal to the vaccination site. Purritic. Present for 3 days before  slowly resolving.
Information has been received from an epidemiologist 1 concerning a 12 year old female who on 17-DEC-1997 was vaccinated with varicella virus vaccine live (Oka/Merck) (1st dose). On 25-JUN-2007 the patient received her second dose of varicella virus vaccine live (Oka/Merck) and broke out with mild chicken pox on 01-AUG-2007. The physician verified this by phone. On 08-AUG-2007 the epidemiologist spoke with the patients father and reported that the chickenpox was not spreading any more. The patient sought unspecified medical attention. Additional information has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site hives in a female patient who received SHINGRIX (batch number B9739, expiry date 22nd November 2020) for prophylaxis. On 13th August 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 13th August 2018, less than a day after receiving SHINGRIX, the patient experienced injection site hives, injection site rash and injection site itching. On an unknown date, the outcome of the injection site hives, injection site rash and injection site itching were recovered/resolved. It was unknown if the reporter considered the injection site hives, injection site rash and injection site itching to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX in left deltoid. The patient experienced itchiness and two hives or bumps at the injection site. All symptoms had resolved. The duration was unknown. The reporter did not had additional patient information.
Day after vaccine, lethargy, aches.   Few days later,  fever, lethargy, shortness of breadth. Nasopharyngeal Covid test 4/12/2021.  Test was positive.   Chest Xray 4/14/21.   There is a new mild hazy infiltrate in the lateral portion of the left  midlung. No definite infiltrate is seen in the right chest.  The findings are suggestive of COVID-19 pneumonia. Covid Infusion 4_15_21 at Clinic.  bamlanivimab-etesevimab 700-1400 mg in 100 mL NS Stopped at 3:45 PM for COVID-19 Continued shortness of breadth for number of weeks.
felt a little roughness; about 7-8 hours of bad chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (felt a little roughness) and CHILLS (about 7-8 hours of bad chills) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION COMPLICATION (felt a little roughness) and CHILLS (about 7-8 hours of bad chills). At the time of the report, VACCINATION COMPLICATION (felt a little roughness) outcome was unknown and CHILLS (about 7-8 hours of bad chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included high blood pressure medication.  Treatment information was not provided.   This case was linked to MOD-2021-345280 (Patient Link).
Caregiver received vaccine dose at 0900 and about 1100 he described feeling numb all over and dizzy. Caregiver was taken to St Joseph Hospital via EMS.
I work up at 2am and could not get back to sleep. I have a chest that is tight and having problems breathing and shortness of breath. Gee what a great idea to give a vaccine that gives me all these side effects. I was fine before I went to the doctors office and I am not fine now.
Mother stated that patient had profuse bouts of epistaxis over the last 24 hours. 5 in total.
Per pt, after getting the Spikevax Moderna vaccine on Monday, she started getting itchy on Tuesday afternoon on her stomach, on her back and on her legs and developed rash until now that it has been 4 days after getting vaccinated. She called her PCP too to report the adverse effect of the vaccine. Per pt, she had Pfizer covid vaccine in the past & had no side effects. We checked database and nothing showed on her record and she requested this time for Moderna.
pt recv vax 23FEB96 & 27-17APR95 devel full blown (not attenuated) varicella illness w/o sequelae or complications;
Moderna covid 19 vaccine administered 15 days after first dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna covid 19 vaccine administered 15 days after first dose) in a 79-year-old male elderly exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 022C21A) , while the parent received the product for COVID-19 vaccination.     No Medical History information was reported.   On 05-May-2021, the parent received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 20-May-2021, the elderly was diagnosed with INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna covid 19 vaccine administered 15 days after first dose). The Elderly was exposed to mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna covid 19 vaccine administered 15 days after first dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No treatment information was reported.
Hospital Course:  61F with ovarian cancer, metastatic to LN and omentum, most recently Carboplatin (4/2021), pelvic XRT (6/2021), with comorbidities of bipolar affective disorder, chronic BLE lymphedema/anasarca, recurrent cellulitis, pAfib, right THA (2019) c/b PJI (9/2020) and sepsis (5/2021), admitted 8/10 with abdominal pain and symptoms from worsening lymphedema/anasarca. Admit complicated by AMS, ongoing pain, and intermittent hypotension (responsive to IVF). Given clinical decline, transition to CMO. Now COVID positive; plan to remain in-house for EOL. We were unable to transfer to an hospice at end of life because of covid infection.    Patient passed peacefully at 7:17 AM on 9/26. She was kept comfortable with a morphine drip and PRN thorazine. Her husband and her outpatient providers were notified. See below for problem based hospital course.
I started to have a cough, congestion, wheezing, fatigue, and a fever. I took over the counter medicines to help reduce the symptoms. I also used my inhaler. I went in to the doctors office the next day and tested positive for Covid. My symptoms lasted for about a week. I am still actively wheezing on and off. I am starting to use Advair to help with the wheezing.
Right after I was administered the vaccine, I felt my heart beating fast and slight dizziness. I think it took about a good hour for it to subside. After wards I was left with extreme exhaustion. The next day my arm was sore and the exhaustion continued. The baby of my head was also hurting so I took Tylenol. Within 48 hours of the vaccine, all symptoms subsided including the sore arm.
besides sore arm, I also had dry heaves, headache x3 days, fever, chills, fatigue
Patient was 18 min post vaccination when she fainted in the observation area. Nursing staff and EMS on site attended to the patient. Nurse reports "patient was sitting in observation. Patine rolled out of her chair on to her stomach on the floor. Patient was unresponsive. Time was 16:50. Patient was rolled onto her back. Patient was sternal rubbed. Patient came to 16:52. She was oriented to person, place, and time." Carotid pulse strong and palpable, spontaneous breathing. EMS vital signs; BP 100/80, HR 92, O2 sat 97%. Pt assisted to wheelchair and taken to private EMS area where she was observed, called family for a ride home. Patient refused EMS transport to hospital.
Flu-like symptoms.; Fever; Muscle aches; Headache; Fatigue.; Nausea.; pain at the injection site; This is a spontaneous report from a contactable consumer (patient). A 38-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EL3248) via an unspecified route of administration (at the age of 38-year-old) on 09Mar2021 at 09:15 AM in left arm as DOSE 2, SINGLE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's medical history included heart disease congenital and drug hypersensitivity. Concomitant medication was not reported. The patient also received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EL3247), via an unspecified route of administration on 17Feb2021 12:00 PM in left arm as DOSE 1, SINGLE for COVID-19 immunisation. There were no other vaccine in four weeks. There were no other medications in two weeks. No COVID prior vaccination. Not tested for COVID post vaccination. There were known allergies: Penicillin. On 19Mar2021 at 09:00 PM, the patient experienced flu-like symptoms, fever, muscle aches, headache, fatigue, nausea. Symptoms were most severe until 24 hours after vaccination. Fatigue and headache continued into day 2 after vaccination with pain at the injection site. The patient underwent lab tests and procedures which included body temperature: 102.8. No treatment was received for the events. The outcome of the events was reported as recovering.  No follow-up attempts are possible. No further information expected.
CLIENT GIVEN VARICELLA VACCINE 9/4/08.  DID NOT DISCLOSE TO NURSE DURING SCREENING QUESTION ON HEALTH HISTORY OF LUPUS.  CLIENT CALLED TO REPORT HAVING CHICKEN POX OUTBREAK 9/6/08.
Felt like he had a mild case of the flu; Felt achy and gross; Didn't feel good; Felt like he had a bad case of the flu; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Felt achy and gross), FEELING ABNORMAL (Didn't feel good), INFLUENZA (Felt like he had a bad case of the flu) and INFLUENZA (Felt like he had a mild case of the flu) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 016B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced PAIN (Felt achy and gross), FEELING ABNORMAL (Didn't feel good) and INFLUENZA (Felt like he had a bad case of the flu). On 21-Apr-2021, the patient experienced INFLUENZA (Felt like he had a mild case of the flu). At the time of the report, PAIN (Felt achy and gross), FEELING ABNORMAL (Didn't feel good), INFLUENZA (Felt like he had a bad case of the flu) and INFLUENZA (Felt like he had a mild case of the flu) had resolved.            No concomitant medication were provided. No treatment information were provided.   This case was linked to MOD-2021-336800 (Patient Link).
Had double vision for the rest of the day/evening. Was fine the following morning.; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received bnt162b2 (BNT162B2), at vaccination age of 68-year-old via an unspecified route of administration in the left arm on 08Mar2021 14:30 (Batch/Lot number was not reported) as a single dose for covid-19 immunisation. The patient medical history was not reported. The patient was not diagnosed with covid-19 prior vaccination. Concomitant medications included lisinopril; montelukast sodium (SINGULAIR) and amlodipine, indication, start and stop date were not reported. The patient did not receive other vaccine in four weeks. The patient previously took acetylsalicylic acid (aspirin), ibuprofen and fexofenadine hydrochloride (ALLEGRA) but had allergies. On 08Mar2021 03:30 PM, the patient had double vision for the rest of the day/evening and was fine the following morning. The patient did not receive treatment for the adverse events. The patient was not covid tested post vaccination. The outcome of the event was recovered on 09Mar2021.  Information about lot/batch number has been requested.
I'm going to take you back to 2006 when my MD, at that time, gave me a pneumonia and tetanus shot in the upper section of my left arm. There was no pain; needle marks; redness; or after affects. I have not had a cold in nine (9) years. Now, I have been cursed!! When I asked for a pneumonia shot, my MD was not the person who administered the shot; who, at no time, explained in full detail what the consequences of the strength of this pneumonia shot would be. The shot was given as follows: The needle was inserted into top of my left shoulder, and it stung. Then, it turned red! When I arrived home, the upper section of my left arm turned RED! It hurt, and there was pain. I put alcohol on the area. In a few days the redness evaporated, but the arm was achy, ad then there was pain. I did contact the doctor's office when the arm turned red, and was told to call back if it became worse. It did get worse. I spoke to Dr., and told him there was pain and severe headaches. He also stated to call him back, if it got worse. I asked him if I could get a stroke or heart attack. He stated: "No." The third call I made was to schedule an appointment with Dr. He suggested an x-ray of my left arm. The results were: beginning of arthritis!! He did mention to take ADVIL twice a day and some light exercise. This is what I eventually took to relieve the pressure and pain: ADVIL or TYLENOL light exercise heating pad. The existing conditions to this day are: Sniffles, runny nose, sneezing, achiness: Joint and muscle, Stiffness: neck; Shoulder, Back, Pain: neck; shoulder arm, headaches, tiredness. On Wednesday, 6 January 2016, a blood red spot appeared on the left side of my left eye. in four (4) days it disappeared. My other medical conditions are; High blood pressure, High cholesterol, Sinus condition, Arthritis. I am allergic to: Penicillin, aspirin, SUDAFED, Lisinopril, Lovastatin, PREVNAR 13. I did report this mele of circumstances to Health Plan, but was told that I only up to 60 days to report any backlash from P-13. I am still experiencing all the conditions listed in this letter. If I had bee given a clearer insight into P-13's shot, I would not have taken it. all medical personnel should thoroughly advise and give a better interpretation of what this pneumonia shot is capable of to all recipients. I am a senior who thought I was going into never-never land!! On Wednesday, 13 January 2016, I contacted Dr's office to have lab work done. The person I spoke with stated she would call me back. She did not. On Friday, 15 January 2016, I call again. She denied talking to me on the 13th. I stated again, about lab work, and she stated in April, I don't trust her. I hope Dr was contacted.
States he received the pneumonia injection, and the site has swollen about the size of a softball. Pain at injection site. Ibuprofen 200 mg qid.
Right arm became painful at the injection site enough that Ibuprofen 400 mg was required; as the evening and night progressed the pain was down the arm and very painful to lift into any range of motion. Unable to lift my right arm above chest high without severe pain. Sleep was disrupted throughout the night. The pain extended into other joints; knees, the next 24 hours and some nausea accompanied the discomfort. It is now 40 hours after the administration of FLUZONE HIGH DOSE and some of the discomfort has subsided, but it is still very uncomfortable to lift my right arm above the level of my chest or to use it to put on my clothes.
Client was sitting in a 15 minute observation after receiving a first dose Pfizer vaccination. She alerted the EMT that she felt lightheaded and then fainted. The EMT was able to catch her and assist her to the floor. Paramedic did a sternal rub and client regained consciousness within 10 seconds. She was then awake, alert and oriented to time , situation, person and place. She was assisted to a wheel chair and zero gravity chair, given water. Vital signs were monitored and  within normal limits, client denied any other symptoms and stated she has a history of vasovagal syncope episodes with other injections. Client ambulated with a steady gait after a total 45 minute observation and resolution of dizziness. She stated she would walk to her home which was close by.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients. On an unspecified date, an unspecified number of patients received an unspecified number of doses of improperly stored VARIVAX (Merck) injection lot#L004653, exp date: 11-FEB-2017; lot#K005426, exp date: 15-APR-2016; lot#J014128, exp date: 07-NOV-2015 (dose, frequency and route of administration not provided). No adverse effect reported and no PQC involved. Additional information has been requested.
Pt presented with episode of hypoglycemia and hypothermia. found at home by some and brought in by ambulance.
fever; achy all over; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (fever) and MYALGIA (achy all over) in a 68-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061D22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE on 03-Mar-2021 and PFIZER BIONTECH COVID-19 VACCINE on 24-Mar-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 13-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Dec-2022, the patient experienced PYREXIA (fever) and MYALGIA (achy all over). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of extra strength and IBUPROFEN (MOTRIN [IBUPROFEN]) for Myalgia, at a dose of 600 milligram. At the time of the report, PYREXIA (fever) and MYALGIA (achy all over) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.
4 days after my first Moderna  vaccine on 2-16-21 I developed a very noticeable shortness of breath. 4 days after my 2nd Moderna vaccine on 3-16-21 I developed tingling on the left side of my face and tingling in the entire left arm.
The initial case was missing the following criteria: unidentifiable patient. Upon receipt of FU information on 12May2015 this case is now considered valid. This is a spontaneous report from a contactable physician. A 75-year-old female patient of an unspecified ethnicity received PREVNAR 13 (Batch/lot# L13518, expiration date 01Jul2016) subcutaneous at 0.5 ml, single at right deltoid on 23Mar2015 10:34. The patient's medical history was not reported. The patient's concomitant medications were not reported. This physician had inadvertently given PREVNAR-13 subcutaneously instead of intramuscularly on 23Mar2015 with outcome of recovered. The patient developed mild cellulitis on 24Mar2015, which responded to antibiotics. The patient was not admitted to hospital, but the event required a physician visit. The patient recovered from cellulitis on 30Mar2015. The physician considered there was not a reasonable possibility that the event was related to the suspect product, but due to incorrect administration. Follow-up attempts completed. No further information expected.
2nd dose at about 9 am on 5/10, by 13:30 or so, fatigue, headache. Second day, felt better, but headache returned around 5 pm.  Subsequent days, headaches more frequent.  Last couple of days, headache woke me up in the middle of the night, and has been pretty much constant since then.  I'm drinking a lot of water - way more than I used to pre-vaccination.  Doesn't seem to help much.  (1st dose, no effect except for localized arm pain at injection site.)
1324 - Vaccine received 1354 - Observation time ended, but developed "itching" to bilateral ears (reported to assessment tent at 1355). History of same plus "heat flushing" to face after 1st dose, which autoresolved without any meds within a few hours the first time. 1400 - HR 85, RR 18, BP 153/109, SpO2 100 1405 - Administered 25 mg PO Benadryl per MD verbal orders. 1410 - D/ced home w/ verbal instructions per MD.
I have experienced extreme redness and swelling that has spread to cover the majority of my upper arm . I have a series of pictures of the progression in symptoms. Covering a total of like a 7x 7 area minimum. The swelling in my arm was severe and has lasted at this point for three days.